Alpha Tau Medical (DRTS) EPS (Basic) (2021 - 2026)

Alpha Tau Medical has disclosed EPS (Basic) across 6 years of filings, most recently posting $88269.2 for Q1 2026.

• EPS (Basic) for Q1 2026 came in at $88269.2, up 24.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $141316.3 (down 3.82% YoY), and the FY2025 annual result was -$0.53, down 17.78% from the prior year.
• EPS (Basic) came in at $88269.2 for Q1 2026 at Alpha Tau Medical, up from $23030.2 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $88269.2 in Q1 2026 to a low of $0.05 in Q4 2022.
• The 5-year median for EPS (Basic) is $23030.2 (2025), against an average of $31640.1.
• Across the five-year window, EPS (Basic) sank 100.0% in 2022 and soared 19871014.05% in 2024, its largest moves.
• Alpha Tau Medical's EPS (Basic) stood at $0.05 in 2022, then jumped by 98.53% to $0.11 in 2023, then jumped by 19871014.05% to $21048.9 in 2024, then climbed by 9.41% to $23030.2 in 2025, then soared by 283.28% to $88269.2 in 2026.
• The last three EPS (Basic) figures came in at $88269.2 (Q1 2026), $23030.2 (Q4 2025), and $30005.1 (Q3 2025), per Business Quant data.